Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSEArca - Delayed Quote USD

Innovator IBD Breakout Opportunities ETF (BOUT)

35.33
-1.17
(-3.22%)
At close: April 3 at 11:40:33 AM EDT

Performance Overview: BOUT

Trailing returns as of 4/3/2025. Category is Mid-Cap Growth.

YTD Return

BOUT
9.57%
Category
0.92%

1-Year Return

BOUT
0.65%
Category
8.25%

3-Year Return

BOUT
1.34%
Category
4.61%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
BOUT
Category
YTD
-1.96%
-0.92%
1-Month
-5.42%
-5.95%
3-Month
-5.53%
-7.41%
1-Year
8.87%
8.25%
3-Year
2.61%
4.61%
5-Year
15.12%
10.24%
10-Year
0.00%
9.46%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
BOUT
Category
2024
18.83%
16.47%
2023
13.27%
21.37%
2022
-22.61%
-27.79%
2021
22.69%
13.05%
2020
50.56%
39.26%
2019
20.59%
32.52%

ETF Summary

The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

ETF Overview

Category Mid-Cap Growth
Fund Family Innovator ETFs
Net Assets 13.42M
YTD Daily Total Return -9.57%
Yield 0.61%
Legal Type Exchange Traded Fund

Related Tickers